184 related articles for article (PubMed ID: 16082334)
21. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.
Schröppel B; Zhang N; Chen P; Zang W; Chen D; Hudkins KL; Kuziel WA; Sung R; Bromberg JS; Murphy B
J Am Soc Nephrol; 2004 Jul; 15(7):1853-61. PubMed ID: 15213273
[TBL] [Abstract][Full Text] [Related]
22. The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats.
Zerwes HG; Li J; Kovarik J; Streiff M; Hofmann M; Roth L; Luyten M; Pally C; Loewe RP; Wieczorek G; Bänteli R; Thoma G; Luckow B
Am J Transplant; 2008 Aug; 8(8):1604-13. PubMed ID: 18557719
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant upregulation of chemokine messenger RNA in non-human primate recipients of intraportal pig islet xenografts.
Hårdstedt M; Finnegan CP; Kirchhof N; Hyland KA; Wijkstrom M; Murtaugh MP; Hering BJ
Xenotransplantation; 2005 Jul; 12(4):293-302. PubMed ID: 15943778
[TBL] [Abstract][Full Text] [Related]
24. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
[TBL] [Abstract][Full Text] [Related]
25. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.
Jiankuo M; Xingbing W; Baojun H; Xiongwin W; Zhuoya L; Ping X; Yong X; Anting L; Chunsong H; Feili G; Jinquan T
J Immunol; 2003 Feb; 170(3):1556-65. PubMed ID: 12538721
[TBL] [Abstract][Full Text] [Related]
26. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
27. Blocking the CC chemokine receptor 5 pathway by antisense peptide nucleic acid prolongs islet allograft survival.
Yang L; Liu YF; Wu G; Zhang JL; Wang FS; Fu DZ; Zhao GH; Li TM
Transplant Proc; 2007; 39(1):185-90. PubMed ID: 17275502
[TBL] [Abstract][Full Text] [Related]
28. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
29. Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients.
Kwun J; Hu H; Schadde E; Roenneburg D; Sullivan KA; DeMartino J; Burlingham WJ; Knechtle SJ
J Immunol; 2007 Dec; 179(12):8016-25. PubMed ID: 18056341
[TBL] [Abstract][Full Text] [Related]
30. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
[TBL] [Abstract][Full Text] [Related]
32. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
[TBL] [Abstract][Full Text] [Related]
33. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
34. CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.
Rosenblum JM; Zhang QW; Siu G; Collins TL; Sullivan T; Dairaghi DJ; Medina JC; Fairchild RL
Transplantation; 2009 Feb; 87(3):360-9. PubMed ID: 19202440
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
Yin R; Zhu J; Shao H; Cheng X; Feng X; Li Z; Jing H
J Heart Lung Transplant; 2007 May; 26(5):485-93. PubMed ID: 17449418
[TBL] [Abstract][Full Text] [Related]
36. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
[TBL] [Abstract][Full Text] [Related]
37. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
[TBL] [Abstract][Full Text] [Related]
38. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
Inston N; Drayson M; Ready A; Cockwell P
Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
[TBL] [Abstract][Full Text] [Related]
39. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.
Melter M; Exeni A; Reinders ME; Fang JC; McMahon G; Ganz P; Hancock WW; Briscoe DM
Circulation; 2001 Nov; 104(21):2558-64. PubMed ID: 11714650
[TBL] [Abstract][Full Text] [Related]
40. Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques.
Carvalho-Gaspar M; Billing JS; Spriewald BM; Wood KJ
J Immunol Methods; 2005 Jun; 301(1-2):41-52. PubMed ID: 16018884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
